Improving Diagnosis in Rare Diseases: Paul Wuh-Liang Hwu, MD, PhD

Video

The professor from National Taiwan University Hospital discussed his work in improving diagnoses in Pompe disease and AADC deficiency.

"Similar to muscle biopsy for Pompe's disease, the standard diagnosis for AADC deficiency is lumbar puncture, a specific type of lumbar puncture that only 1 or 2 labs in in each state. So, it's a huge obstacle in the diagnosis of this disease. There are certainly many patients with AADC deficiency that are not diagnosed."

While international Rare Disease Day has come and gone, improving awareness of these diseases, such as aromatic L-amino acid decarboxylase (AADC) deficiency, Pompe disease, and spinal muscular atrophy, remains an ongoing issue.

Advances continue to be made in these diseases, especially with cell and gene therapies. One such gene therapy under investigation in AADC deficiency is PTC Therapeutics’ PTC-AADC. The therapy is being evaluated in trials at National Taiwan University Hospital, where Paul Wuh-Liang Hwu, MD, PhD, professor of pediatrics, serves as an investigator.

CGTLive spoke with Hwu to learn more about unmet needs that remain in AADC deficiency and Pompe disease. He discussed issues in diagnosing these diseases, how diagnoses could be improved, and a diagnostic assay the hospital has developed in facilitating diagnosis of AADC deficiency.

Related Videos
Akshay Sharma, MBBS, a bone marrow transplant physician at St. Jude Children’s Research Hospital
M. Peter Marinkovich, MD, on Bringing RDEB Treatment to the Local Level
Caspian Oliai, MD, MS, the medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Frederick “Eric” Arnold, PhD
Genovefa (Zenia) Papanicolaou, MD, an infectious diseases specialist at Memorial Sloan Kettering Cancer Center
Jeffrey Chamberlain, PhD, on Exciting New Research at MDA 2024
Alan Beggs, PhD, on Challenges in Therapeutic Development for Rare Diseases
Akshay Sharma, MBBS, a bone marrow transplant physician at St. Jude Children’s Research Hospital
PJ Brooks, PhD
John DiPersio, MD, PhD, the director of the Center for Gene and Cellular Immunotherapy at Washington University School of Medicine
© 2024 MJH Life Sciences

All rights reserved.